In continuation of disclosures dated February 9, 2023 and February 14, 2023 respectively, and pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) Camlin Fine Sciences has informed that the transcript of the earnings conference call held on February 14, 2023 on the Un-audited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2022 is enclosed and is also available at the Company’s website at https://www.camlinfs.com/investorcallrecording. The Management was represented by Ashish Dandekar, Chairman & Managing Director, Nirmal Momaya, Managing Director and Santosh Parab, Chief Financial Officer.
The above information is a part of company’s filings submitted to BSE.
